This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
over 65
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The purpose of this study is to explore the efficacy of bevacizumab combined with radiotherapy compared with radiotherapy alone in the treatment of newly diagnosed glioblastoma in the elderly. - Trial with medicinal product

Provided treatments

  • Drug: Bevacizumab
  • Radiation: Radiation therapy

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01443676. The sponsor of the trial is University of Zurich and it is looking for 75 volunteers for the current phase.
Official trial title:
Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma